ArticleJournal of cellular and molecular medicine2020

FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1.

Rui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.